- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 16th, 2004
Biophan Technologies, Inc., a developer of next-generation biomedical technology, has appointed biotechnology executive John Lanzafame to serve as president of the Company's Nanolution division, according to Biophan CEO Michael Weiner.
As Nanolution president, Mr. Lanzafame will oversee Biophan's development of advanced nanotechnology-based drug delivery devices and drug-elution technologies, patents, and products.
|Related News Press|
Discovery of the specific properties of graphite-based carbon materials February 6th, 2016
Study reveals how herpes virus tricks the immune system February 5th, 2016
Hepatitis virus-like particles as potential cancer treatment February 5th, 2016
Semblant Appoints Donald Cunningham as Chief Commercial Officer January 2nd, 2016